 better than insulin when it comes to lowering your chances of getting certain cancers. The study finding drugs like Ozempic and Magovi were associated with a lower risk of 10 obesity-related cancers in patients with type 2 diabetes, including pancreatic and ovarian cancers. Daria Albinger, ABC News.